BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

560 related articles for article (PubMed ID: 26652877)

  • 1. The role of neuroimaging in the diagnosis of the atypical parkinsonian syndromes in clinical practice.
    Dąbrowska M; Schinwelski M; Sitek EJ; Muraszko-Klaudel A; Brockhuis B; Jamrozik Z; Sławek J
    Neurol Neurochir Pol; 2015; 49(6):421-31. PubMed ID: 26652877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiation of progressive supranuclear palsy: clinical, imaging and laboratory tools.
    Liscic RM; Srulijes K; Gröger A; Maetzler W; Berg D
    Acta Neurol Scand; 2013 May; 127(5):362-70. PubMed ID: 23406296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic criteria for multiple system atrophy and progressive supranuclear palsy.
    Wenning GK; Colosimo C
    Rev Neurol (Paris); 2010 Oct; 166(10):829-33. PubMed ID: 20813385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Regional cerebral blood flow single photon emission tomography (SPECT) and magnetic resonance imaging (MRI) may be useful in the diagnosis of patients with cortico-basal degeneration, progressive supranuclear palsy and multiple system atrophy].
    Lass P; Sławek J; Derejko M; Dubaniewicz M
    Neurol Neurochir Pol; 2003; 37 Suppl 5():263-74. PubMed ID: 15098354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcranial sonography and [18F]fluorodeoxyglucose positron emission tomography for the differential diagnosis of parkinsonism: a head-to-head comparison.
    Hellwig S; Reinhard M; Amtage F; Guschlbauer B; Buchert R; Tüscher O; Weiller C; Niesen WD; Meyer PT
    Eur J Neurol; 2014 Jun; 21(6):860-6. PubMed ID: 24602186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnostic criteria of parkinsonian syndromes].
    Tison F
    Rev Neurol (Paris); 2003 May; 159(5 Pt 2):3S19-23. PubMed ID: 12773884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [¹⁸F]FDG-PET is superior to [¹²³I]IBZM-SPECT for the differential diagnosis of parkinsonism.
    Hellwig S; Amtage F; Kreft A; Buchert R; Winz OH; Vach W; Spehl TS; Rijntjes M; Hellwig B; Weiller C; Winkler C; Weber WA; Tüscher O; Meyer PT
    Neurology; 2012 Sep; 79(13):1314-22. PubMed ID: 22914831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parkinson's Disease Diagnostic Observations (PADDO): study rationale and design of a prospective cohort study for early differentiation of parkinsonism.
    van Rumund A; Aerts MB; Esselink RAJ; Meijer FJA; Verbeek MM; Bloem BR
    BMC Neurol; 2018 May; 18(1):69. PubMed ID: 29764386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Atypical" atypical parkinsonism: Critical appraisal of a cohort.
    Hirschbichler ST; Erro R; Ganos C; Stamelou M; Batla A; Balint B; Bhatia KP
    Parkinsonism Relat Disord; 2017 Apr; 37():36-42. PubMed ID: 28236526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lumping and splitting the Parkinson Plus syndromes: dementia with Lewy bodies, multiple system atrophy, progressive supranuclear palsy, and cortical-basal ganglionic degeneration.
    Mark MH
    Neurol Clin; 2001 Aug; 19(3):607-27, vi. PubMed ID: 11532646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential diagnosis of Parkinson's disease and atypical parkinsonian disorders by magnetic resonance imaging.
    Savoiardo M
    Neurol Sci; 2003 May; 24 Suppl 1():S35-7. PubMed ID: 12774211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Differential diagnosis of parkinsonian syndromes using MRI].
    Mahlknecht P; Schocke M; Seppi K
    Nervenarzt; 2010 Oct; 81(10):1168-79. PubMed ID: 20857276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain magnetic resonance imaging techniques in the diagnosis of parkinsonian syndromes.
    Seppi K; Poewe W
    Neuroimaging Clin N Am; 2010 Feb; 20(1):29-55. PubMed ID: 19959017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MRI for the differential diagnosis of neurodegenerative parkinsonism in clinical practice.
    Seppi K
    Parkinsonism Relat Disord; 2007; 13 Suppl 3():S400-5. PubMed ID: 18267272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lower urinary tract dysfunction in Parkinsonian syndromes.
    Vichayanrat E; Hentzen C; Batla A; Simeoni S; Iodice V; Panicker JN
    Neurol Sci; 2021 Oct; 42(10):4045-4054. PubMed ID: 34318363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffusion tensor imaging differentiates vascular parkinsonism from parkinsonian syndromes of degenerative origin in elderly subjects.
    Deverdun J; Menjot de Champfleur S; Cabello-Aguilar S; Maury F; Molino F; Charif M; Leboucq N; Ayrignac X; Labauge P; Bonafe A; Castelnovo G; Le Bars E; Geny C; Menjot de Champfleur N
    Eur J Radiol; 2014 Nov; 83(11):2074-9. PubMed ID: 25154005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Atypical Parkinson syndromes--recent advances in diagnosis and therapy].
    Duerr S; Wenning GK; Seppi K; Poewe W
    Fortschr Neurol Psychiatr; 2012 Sep; 80(9):492-500. PubMed ID: 22457226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of gray matter atrophy in atypical parkinsonism syndromes: a VBM meta-analysis.
    Yu F; Barron DS; Tantiwongkosi B; Fox P
    Brain Behav; 2015 Jun; 5(6):e00329. PubMed ID: 26085961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic Approach to Atypical Parkinsonian Syndromes.
    McFarland NR
    Continuum (Minneap Minn); 2016 Aug; 22(4 Movement Disorders):1117-42. PubMed ID: 27495201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The differential diagnosis of Parkinson's disease.
    Poewe W; Wenning G
    Eur J Neurol; 2002 Nov; 9 Suppl 3():23-30. PubMed ID: 12464118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.